P

Inventor

HAYTER GARY A

US63 patents
⚠️ This page may combine multiple inventors who share the name “HAYTER GARY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT DIABETES CARE INC

38 patents
USD1030780SJun 11, 2024

Display screen or portion thereof with graphical user interface for continuous glucose monitoring

ABBOTT DIABETES CARE INC16 citations94
USD994695SAug 8, 2023

Display screen or portion thereof with graphical user interface for continuous glucose monitoring

ABBOTT DIABETES CARE INC25 citations94
US10398363B2Sep 3, 2019

Temperature-compensated analyte monitoring devices, systems, and methods thereof

ABBOTT DIABETES CARE INC12 citations92
US9351670B2May 31, 2016

Glycemic risk determination based on variability of glucose levels

ABBOTT DIABETES CARE INC21 citations92
USD957438SJul 12, 2022

Display screen or portion thereof with graphical user interface

ABBOTT DIABETES CARE INC16 citations91
US11213622B2Jan 4, 2022

Usability features for integrated insulin delivery system

ABBOTT DIABETES CARE INC6 citations86
US11039767B2Jun 22, 2021

Method and apparatus for providing data processing and control in medical communication system

ABBOTT DIABETES CARE INC12 citations86
US10685749B2Jun 16, 2020

Insulin delivery apparatuses capable of bluetooth data transmission

ABBOTT DIABETES CARE INC13 citations86
US11331051B2May 17, 2022

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

ABBOTT DIABETES CARE INC4 citations84
US11207006B2Dec 28, 2021

Systems, devices, and methods for energy efficient electrical device activation

ABBOTT DIABETES CARE INC4 citations84
US11004566B2May 11, 2021

Systems, devices, and methods for episode detection and evaluation

ABBOTT DIABETES CARE INC7 citations84
US10872696B2Dec 22, 2020

Method of hypoglycemia risk determination

ABBOTT DIABETES CARE INC7 citations84
US10130765B2Nov 20, 2018

Integrated insulin delivery system having safety features to prevent hypoglycemia

ABBOTT DIABETES CARE INC4 citations84
US10028686B2Jul 24, 2018

Methods for generating hybrid analyte level output, and devices and systems related thereto

ABBOTT DIABETES CARE INC8 citations84
US10019554B2Jul 10, 2018

Glycemic risk determination based on variability of glucose

ABBOTT DIABETES CARE INC6 citations84
US9872641B2Jan 23, 2018

Methods, devices, and systems related to analyte monitoring

ABBOTT DIABETES CARE INC8 citations83
US9402953B2Aug 2, 2016

Integrated closed-loop medication delivery with error model and safety check

ABBOTT DIABETES CARE INC6 citations83
USD1015366SFeb 20, 2024

Display screen or portion thereof with graphical user interface

ABBOTT DIABETES CARE INC9 citations82
US10923218B2Feb 16, 2021

Data synchronization between two or more analyte detecting devices in a database

ABBOTT DIABETES CARE INC6 citations82
US10010291B2Jul 3, 2018

System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk

ABBOTT DIABETES CARE INC8 citations82
USD1038141SAug 6, 2024

Display screen or portion thereof with graphical user interface

ABBOTT DIABETES CARE INC10 citations80
US12350041B2Jul 8, 2025

Systems, devices, and methods for energy efficient electrical device activation

ABBOTT DIABETES CARE INC1 citations75
US11571147B2Feb 7, 2023

Temperature-compensated analyte monitoring devices, systems, and methods thereof

ABBOTT DIABETES CARE INC1 citations73
US10888272B2Jan 12, 2021

Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation

ABBOTT DIABETES CARE INC2 citations73
US11304664B2Apr 19, 2022

System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk

ABBOTT DIABETES CARE INC2 citations72
US11246986B2Feb 15, 2022

Integrated closed-loop medication delivery with error model and safety check

ABBOTT DIABETES CARE INC3 citations72
US11424015B2Aug 23, 2022

Devices, systems, and methods for analyte monitoring having a selectable or variable response rate

ABBOTT DIABETES CARE INC2 citations71
US10108781B2Oct 23, 2018

Glucose or ketone body analyte monitoring in vivo

ABBOTT DIABETES CARE INC2 citations71
US12310721B2May 27, 2025

Method and apparatus for providing data processing and control in medical communication system

ABBOTT DIABETES CARE INC0 citations63
US12268844B2Apr 8, 2025

Integrated insulin delivery system having safety features to prevent hypoglycemia

ABBOTT DIABETES CARE INC0 citations63
US12440126B2Oct 14, 2025

Temperature-compensated analyte monitoring devices, systems, and methods thereof

ABBOTT DIABETES CARE INC0 citations62
US12424326B2Sep 23, 2025

Systems, devices, and methods for episode detection and evaluation

ABBOTT DIABETES CARE INC0 citations62
US12397111B2Aug 26, 2025

Continuous glucose monitoring system

ABBOTT DIABETES CARE INC0 citations62
US12290354B2May 6, 2025

Temperature-compensated analyte monitoring devices, systems, and methods thereof

ABBOTT DIABETES CARE INC0 citations62
US12178617B2Dec 31, 2024

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

ABBOTT DIABETES CARE INC0 citations62
US12102454B2Oct 1, 2024

Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

ABBOTT DIABETES CARE INC0 citations62
US11633127B2Apr 25, 2023

Methods, devices, and systems related to analyte monitoring

ABBOTT DIABETES CARE INC0 citations62
US11633126B2Apr 25, 2023

Methods, devices, and systems related to analyte monitoring

ABBOTT DIABETES CARE INC0 citations62

BUDIMAN ERWIN S

3 patents

WILINSKA MALGORZATA E

2 patents

BERNSTEIN DANIEL M

2 patents

SLOAN MARK

1 patent

VISTA RESEARCH INC

1 patent

HAYTER GARY A

1 patent

FERN JONATHAN

1 patent

WEI CHARLES

1 patent

Showing the top 50 of 63 patents by PatentIndex Score.